bioRxivMicrobiologyPreprint
Incidence, antifungal resistance properties, and virulence traits of candida species isolated from HIV/AIDS Patients from the hospital system in Kenya.
Abstract
Candidiasis is the most common fungal infection in hospitalized patients with acquired immune deficiency syndrome resulting to morbidity and mortality. This study aimed at characterizing, incidence, susceptibility, resistance genes, antibiofilm activity, and virulence traits of Candida species isolated from HIV-Infected patients. One hundred and eighty-one samples were collected and cultured on Sabouraud Dextrose Agar, biochemical tests and confirmed using automated Vitek-2 (R) Compact bioMerieux followed by susceptibility tests. were done by use of various conventional antifungals against the isolates using standard procedures. Virulence factors, biofilm formations and resistance genes of Candida strains were determined. Out of the 181 samples, 46 were identified as Candida spp., 20 C. albicans (43.5%), 6 C. tropicalis (13.0%), 8 C. krusei (17.4%), 4 C. glabrata (8.7%), 3 C. famata (6.5%), 3 C. parapsilosis (6.5%), and 2 C. guilliermondii (4.3%). All the Candida albicans isolated were both Gram positive and Germ test tube test positive. Eighteen (90%) of the isolates were susceptible to Clotrimazole at a concentration of 5 g/mL - 10g/mL followed by 17 (85%) isolates to Panosoconazole at a concentration of 0.002 g/mL - 5g/mL. Eight (40.0 %) of the Candida albicans isolates possessed the gene (cdr1) that was observed at 286 bp. Virulence enzymes was determined in which 100% produced Haemolysin, followed by proteinase (75.0%), phospholipase (50%), coagulase at (50%) and lastly capsulase (25.0%). Fluconazole and Clotrimazole did not inhibit growth of C. albicans at high concentrations but from our study, it was deduced that they inhibit biofilm formation at lower concentrations. C. albicans isolates were resistant to multiple antifungal including those commonly used in the management on HIV/AIDs patient. This attributed to resistant genes and produced various virulence factors that were found to be present in the isolates. Therefore, there is a need to carry out regular surveillance on antifungal drug resistance.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Candida species isolated in female patients of reproductive age with vaginal candidiasis in Gualeguaychu, Entre Rios, Argentina
Pérez Duarte Iván Rodrigo, Razetto Georgina, … Juárez María Josefina·bioRxiv·Nov 2, 2024
- ANIDULAFUNGIN AND HUMAN MONOCYTES REDUCE Candida spp. BIOFILM WITH DIFFERENT FUNGAL BIOMASS.
Paula Alejandra Icely, Sofia Carla Angiolini, … Claudia Elena Sotomayor·bioRxiv·Mar 3, 2025
- Aqueous Spice Extracts as Alternative Antimycotics to Control Highly Drug Resistant Extensive Biofilm Forming Clinical Isolates of Candida albicans
B. Sadanandan, V. Vijayalakshmi, … R. Awaknavar·bioRxiv·Jan 17, 2023
- Heterogeneity of Candida bloodstream isolates in an academic medical center and affiliated hospitals
Nancy E. Scott, Elizabeth Wash, … Anna M. Selmecki·Microbiology SpectrumPeer-reviewed·Jun 23, 2025
- Combination of antifungal drugs and protease inhibitors prevent Candida albicans biofilm formation and disrupt mature biofilms
M. B. Lohse, M. Gulati, … C. J. Nobile·bioRxiv·Feb 11, 2020
- Differential response of Candida species morphologies and isolates to fluconazole and boric acid
O. E. Salama, A. C. Gerstein·bioRxiv·Jan 9, 2022